CD15 MicroBeads, human

CD15 MicroBeads, human

CD15 MicroBeads were developed for positive selection or depletion of CD15
cells from human lysed peripheral blood or single-cell suspensions from tissues.

Background information

The CD15 antibody recognizes a 3-fucosyl-N-acetyllactosamine carbohydrate modification in glycolipids or glycoproteins. The CD15 antigen is expressed on neutrophils, eosinophils, and monoblastoid precursor cells of the myeloid lineage but not on basophils and lymphocytes. The antigen is also present on Hodgkin/Reed-Sternberg cells.

Downstream applications

CD15 MicroBeads are used for the isolation
or depletion of human eosinophils and neutrophils (basophils are CD15
) from peripheral blood and from tissues such as ovarian carcinoma tissue.
Furthermore, CD15 MicroBeads can be used for the depletion of myeloid cells from bone marrow.


For positive selection: MS, LS, XS, or autoMACS
Columns. For depletion: LD, D, or autoMACS Columns.
  • Selected references

    1. Zahler, S. et al. (1997) The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J. Immunol. Methods 200: 173-179
    2. Harbeck, N. et al. (1995) Model system for isolation of competent ovarian-carcinoma cells from fresh tumor-tissue by a magnetic separation technique (MACS). Int. J. Oncol. 6: 1249-1254
Product options: 1
for 1×
total cells
CHF  703.00

Related products

4 products available